Treatment of vaginal candidiasis in pregnancy with a single clotrimazole 500 mg vaginal pessary
CITATION: Lindeque, B. G. & Van Niekerk, W. A. 1984. South African Medical Journal, 65:123-124.
The original publication is available at http://www.samj.org.za
A single vaginal pessary containing clotrimazole 500 mg (Canesten; Bayer-Miles) was used to treat candidiasis during a prospective, mycologically controlled trial among 46 patients in the second and third trimesters of pregnancy. Positive cultures were obtained from vaginal swabs before commencement of treatment. Swabs were taken 1 week and 1 month after treatment. Four patients were lost to follow-up. One week after treatment 83.3% of the patients were cured on microscopic and mycological examination, and all of the patients had relief of symptoms. The recurrence rate was 5.7% after 1 month. Of the 7 patients in whom treatment was unsuccessful, 3 were available for repeat treatment and all 3 responded successfully to a second course.